BIO

Bio Rad Laboratories Inc

Add to Watchlist

Advanced Chart

254.930

-9.26(-3.505%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

262.045

Open

261.410

VWAP

Vol

140.26K

Mkt Cap

7.19B

Low

252.370

Amount

EV/EBITDA(TTM)

14.38

Total Shares

28.52M

6.64B

EV/OCF(TTM)

13.68

P/S(TTM)

2.92

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

684.91M

+2.61%

2.706

-6.69%

633.81M

-2.45%

1.709

-14.95%

614.29M

-3.79%

1.746

-43.85%

Estimates Revision

The market is revising Downward the revenue expectations for Bio-Rad Laboratories, Inc. (BIO) for FY2025, with the revenue forecasts being adjusted by -1.61% over the past three months. During the same period, the stock price has changed by 6.15%.

Revenue Estimates for FY2025

Revise Downward

-1.61%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-9.71%

In Past 3 Month

Stock Price

Go Up

+6.15%

In Past 3 Month

4 Analyst Rating

26.70% Upside

Wall Street analysts forecast BIO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BIO is 323.00 USD with a low forecast of 245.00 USD and a high forecast of 387.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

26.70% Upside

Current: 254.930

Low

245.00

Averages

323.00

High

387.00

26.70% Upside

Current: 254.930

Low

245.00

Averages

323.00

High

387.00

Wells Fargo

Equal Weight

downgrade

$260 -> $245

2025-06-08

Reason

Wells Fargo

Price Target

$260 -> $245

2025-06-08

downgrade

Equal Weight

Reason

Wells Fargo lowered the firm's price target on Bio-Rad to $245 from $260 and keeps an Equal Weight rating on the shares. The firm reduced estimates to reflect revised assumptions for life science growth in the second half of 2025 and 2026.

Wells Fargo

Brandon Couillard

Hold

Maintains

$320 → $270

2025-04-17

Reason

Wells Fargo

Brandon Couillard

Price Target

$320 → $270

2025-04-17

Maintains

Hold

Reason

RBC Capital

Conor McNamara

Buy

Reiterates

$481

2025-01-14

Reason

RBC Capital

Conor McNamara

Price Target

$481

2025-01-14

Reiterates

Buy

Reason

RBC Capital

Conor McNamara

Buy

Maintains

$369 → $481

2024-12-09

Reason

RBC Capital

Conor McNamara

Price Target

$369 → $481

2024-12-09

Maintains

Buy

Reason

Citigroup

Patrick Donnelly

Strong Buy

Maintains

$400 → $450

2024-10-31

Reason

Citigroup

Patrick Donnelly

Price Target

$400 → $450

2024-10-31

Maintains

Strong Buy

Reason

RBC Capital

Conor McNamara

Buy

Maintains

$446 → $469

2024-10-31

Reason

RBC Capital

Conor McNamara

Price Target

$446 → $469

2024-10-31

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Bio Rad Laboratories Inc (BIO.N) is 31.10, compared to its 5-year average forward P/E of 37.72. For a more detailed relative valuation and DCF analysis to assess Bio Rad Laboratories Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

37.72

Current PE

31.10

Overvalued PE

49.38

Undervalued PE

26.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

23.43

Current EV/EBITDA

15.96

Overvalued EV/EBITDA

30.66

Undervalued EV/EBITDA

16.19

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

4.93

Current PS

2.78

Overvalued PS

6.60

Undervalued PS

3.27

Financials

Annual

Quarterly

FY2025Q1

YoY :

-4.16%

585.40M

Total Revenue

FY2025Q1

YoY :

+9.83%

56.90M

Operating Profit

FY2025Q1

YoY :

-83.33%

64.00M

Net Income after Tax

FY2025Q1

YoY :

-82.97%

2.29

EPS - Diluted

FY2025Q1

YoY :

+222.37%

95.50M

Free Cash Flow

FY2025Q1

YoY :

-0.73%

53.06

Gross Profit Margin - %

FY2025Q1

YoY :

+83.57%

13.07

FCF Margin - %

FY2025Q1

YoY :

-82.61%

10.93

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

741.2K

USD

6-9

Months

0.0

USD

0-12

Months

1.2M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 333305.8% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

63.7K

Volume

6-9

Months

119.5K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

230.1K

Volume

Months

6-9

69.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

741.2K

USD

6-9

Months

0.0

USD

0-12

Months

1.2M

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

BIO News & Events

Events Timeline

2025-07-07 (ET)

2025-07-07

09:23:59

Bio-Rad expands digital PCR offering with new platforms

2025-05-01 (ET)

2025-05-01

16:26:34

Bio-Rad now sees non-GAAP revenue for FY down 1% to up 1.5%

2025-05-01

16:26:08

Bio-Rad reports Q1 EPS $2.54, consensus $1.78

News

9.5

07-17Yahoo Finance

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

5.0

07-07Newsfilter

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

4.0

06-09Benzinga

5 Analysts Have This To Say About Bio-Rad Laboratories

People Also Watch

FAQ

What is Bio Rad Laboratories Inc (BIO) stock price today?

The current price of BIO is 254.93 USD — it has decreased -3.51 % in the last trading day.

BIO

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

BIO News & Events

Events Timeline

News

People Also Watch

FAQ

What is Bio Rad Laboratories Inc (BIO) stock price today?

What is Bio Rad Laboratories Inc (BIO)'s business?

What is the price predicton of BIO Stock?

What is Bio Rad Laboratories Inc (BIO)'s revenue for the last quarter?

What is Bio Rad Laboratories Inc (BIO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Bio Rad Laboratories Inc (BIO)'s fundamentals?

How many employees does Bio Rad Laboratories Inc (BIO). have?

What is Bio Rad Laboratories Inc (BIO) market cap?